Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8931106 | 1.00 | ALDH1A1 (0.47) | ALDH1A1HSD17B10SLC2A1LMNAMEN1 | |
| SCHEMBL8817632 | 1.00 | ALDH1A1 (0.47) | ALDH1A1HSD17B10SLC2A1LMNAMEN1 | |
| Ammonia Solution, Strong SCHEMBL28389948 | 0.98 | ALDH1A1 (0.46) | ALDH1A1HSD17B10SLC2A1LMNAMEN1 | |
| Piperidine SCHEMBL28556095 | 0.87 | LMNA (0.44) | ALDH1A1HSD17B10SLC2A1LMNAMEN1 | |
| SCHEMBL7722439 | 0.79 | ALDH1A1 (0.54) | ALDH1A1HSD17B10LMNAMEN1CYP1A2 | |
| SCHEMBL14965898 | 0.79 | ALDH1A1 (0.54) | ALDH1A1HSD17B10LMNAMEN1CYP1A2 | |
| SCHEMBL16209547 | 0.79 | ALDH1A1 (0.54) | ALDH1A1HSD17B10LMNAMEN1CYP1A2 | |
| SCHEMBL9879491 | 0.79 | ALDH1A1 (0.44) | ALDH1A1HSD17B10LMNAMEN1CYP1A2 | |
| SCHEMBL28352710 | 0.79 | ALDH1A1 (0.45) | ALDH1A1HSD17B10LMNAMEN1CYP1A2 | |
| SCHEMBL15094402 | 0.79 | SLC2A1 (0.43) | ALDH1A1SLC2A1MAPTKMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118373791-A | Allyl phthalide compound and preparation method and application thereof | 南京工业大学 | 2024-07-23 | — | — | CN | claimed |
| CN-117897055-A | Method for reducing abnormal odor | 奇华顿股份有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-117860736-A | Butylphthalide composition and application thereof in treating testicular ischemia reperfusion | 延安大学咸阳医院有限公司 | 2024-04-12 | — | — | CN | claimed |
| US-11684559-B2 | Topical cosmetic treatment of skin and scalp and corresponding active ingredient based on an extract of Apium graveolens | SEDERMA (FR) | 2023-06-27 | — | — | US | claimed |
| CN-111670027-B | Cosmetic use of cyclic peptides | 赛德玛公司 | 2023-06-06 | — | — | CN | claimed |
| CN-110698445-B | 3-amine alkyl phthalide compound, preparation method and application thereof | 四川大学 | 2023-05-12 | — | — | CN | claimed |
| CN-115554289-A | Pharmaceutical active composition containing butylphthalide and preparation method thereof | 成都施贝康生物医药科技有限公司 | 2023-01-03 | — | — | CN | claimed |
| CN-109789080-B | Alkyl phthalides for use in cosmetic treatment of nails | 赛德玛公司 | 2022-06-24 | — | — | CN | claimed |
| US-20220062139-A1 | TOPICAL COSMETIC TREATMENT OF SKIN AND SCALP AND CORRESPONDING ACTIVE INGREDIENT BASED ON AN EXTRACT OF APIUM GRAVEOLENS | SEDERMA (FR) | 2022-03-03 | — | — | US | claimed |
| US-11166897-B2 | Topical cosmetic treatment of scalp and corresponding active ingredient based on an extract of Apium graveolens | SEDERMA (FR) | 2021-11-09 | — | — | US | claimed |
| US-20180078481-A1 | TOPICAL COSMETIC TREATMENT OF SKIN AND SCALP AND CORRESPONDING ACTIVE INGREDIENT BASED ON AN EXTRACT OF APIUM GRAVEOLENS | SEDERMA (FR) | 2018-03-22 | — | — | US | claimed |
| EP-3277254-A1 | TOPICAL COSMETIC TREATMENT OF SKIN AND SCALP AND CORRESPONDING ACTIVE INGREDIENT BASED ON AN EXTRACT OF APIUM GRAVEOLENS | SEDERMA (FR) | 2018-02-07 | — | — | EP | claimed |
| CN-107396627-A | The processing of the local beauty of skin and scalp and the accordingly active component based on Herba Apii graveolentis extract | 赛德玛公司 | 2017-11-24 | — | — | CN | claimed |
| WO-2016157073-A1 | TOPICAL COSMETIC TREATMENT OF SKIN AND SCALP AND CORRESPONDING ACTIVE INGREDIENT BASED ON AN EXTRACT OF APIUM GRAVEOLENS | SEDERMA (FR) | 2016-10-06 | — | — | WO | claimed |
| US-20150045564-A1 | Cu-MEDIATED ANNULATION FOR THE EFFECTIVE SYNTHESIS OF 3-SUBSTITUTED PHTHALIDES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-02-12 | — | — | US | claimed |
| WO-2013102935-A2 | Cu-MEDIATED ANNULATION FOR THE EFFECTIVE SYNTHESIS OF 3-SUBSTITUTED PHTHALIDES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2013-07-11 | — | — | WO | claimed |
| US-20050087725-A1 | Thermochromic tire | KANAKKANATT SEBASTINA V (US) | 2005-04-28 | — | — | US | claimed |
| US-6326006-B1 | ACCELERATING BLOOD CIRCULATION, BODY WARMING AND RETENTION OF WARMTH; COMPRISES ALKYL PHTHALIDE, ALKOXY PHTHALIDE, ALKYLIDENE PHTHALIDE OR MIXTURE | KAO CORPORATION (JP) | 2001-12-04 | — | — | US | claimed |
| EP-0357081-B1 | Bathing preparation | KAO CORP (JP) | 1995-01-04 | — | — | EP | claimed |
| EP-0357081-A2 | Bathing preparation | Kao Corporation (JP) | 1990-03-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180078481-A1 | TOPICAL COSMETIC TREATMENT OF SKIN AND SCALP AND CORRESPONDING ACTIVE INGREDIENT BASED ON AN EXTRACT OF APIUM GRAVEOLENS | SAP18, CYP51A1, NAA10 | ALDH1A1 863/4885HSD17B10 29/4885SLC2A1 4606/4885 |
| US-20220062139-A1 | TOPICAL COSMETIC TREATMENT OF SKIN AND SCALP AND CORRESPONDING ACTIVE INGREDIENT BASED ON AN EXTRACT OF APIUM GRAVEOLENS | SAP18, CYP51A1, NAA10 | ALDH1A1 863/4885HSD17B10 29/4885SLC2A1 4606/4885 |
| US-11684559-B2 | Topical cosmetic treatment of skin and scalp and corresponding active ingredient based on an extract of Apium graveolens | SAP18, CYP51A1, NAA10 | ALDH1A1 863/4885HSD17B10 29/4885SLC2A1 4606/4885 |
| US-20150045564-A1 | Cu-MEDIATED ANNULATION FOR THE EFFECTIVE SYNTHESIS OF 3-SUBSTITUTED PHTHALIDES | SOD1, AOC2, SOD3 | ALDH1A1 97/4885HSD17B10 753/4885SLC2A1 3834/4885 |
| US-11166897-B2 | Topical cosmetic treatment of scalp and corresponding active ingredient based on an extract of Apium graveolens | SAP18, CYP51A1, NASP | ALDH1A1 933/4885HSD17B10 22/4885SLC2A1 4737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.